Guide Note

On May 28, 2008, pharmaceutical giant Pfizer announced that attorney Amy Schulman had been hired as general counsel.

The 47-year-old Schulman was a partner at the DLA Piper law firm in New York City for many years. During that time, she represented Pfizer in its litigation involving the drugs Bextra and Celebrex.

Fast Facts

Full name: Amy W. Schulman

Takes over Pfizer job on June 23, 2008

Replaces Allan Waxman

Joined DLA Piper in 1997

Education: Wesleyan University and Yale University Law School

Quote

"We know first hand the outstanding qualities that Amy brings to us. Her knowledge of the legal, business and regulatory challenges facing the pharmaceutical industry and her experience tackling large, complex cases make her uniquely qualified to lead Pfizer’s legal team."— Jeffrey Kindler, Pfizer CEO

Amy Schulman

Also try: Pfizer

Amy Schulman News and Information

DLA Piper: Amy Schulman Profile
The Wall Street Journal: Schulman Poised to Take Top Legal Post at Pfizer (May 28, 2008)
Reuters UK: Pfizer Names New General Counsel (May 28, 2008)
Business Wire: Pfizer Names Amy W. Schulman as Senior Vice President... (May 28, 2008)
Legal Week: DLA Piper's '$60m' Litigator Goes In-House with Pfizer Role (May 28, 2008)
Topix.net: Amy Schulman
Google News: Amy Schulman

Amy Schulman Blogs and Commentaries

Law Blog (WSJ): DLA's Amy Schulman Lands Top Legal Job at Pfizer (May 28, 2008)
PharmaGossip: Meet Amy Schulman - Pfizer's New Top Lawyer (May 28, 2008)
Google Blog Search: Amy Schulman